Brandi Bailey
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Signaling Pathways in Disease 4
- Cancer therapeutics and mechanisms 3
- Pluripotent Stem Cells Research 3
- Oncology 11
- Peptidase Inhibition and Analysis 5
- Co-authors
- Mark A. Sussman (9 shared papers)Natalie Gude (8 shared papers)Christopher T. Cottage (7 shared papers)Christina C. Niemeyer (7 shared papers)Lorenzo M. Leoni (7 shared papers)Heather Bendall (7 shared papers)Jack Reifert (7 shared papers)Jacques Corbeil (2 shared papers)
- Journals
- Cancer Research (4 papers)Circulation Research (3 papers)Blood (2 papers)Stem Cells (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Brandi Bailey
18 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Genetics 230
- Pathology and Forensic Medicine 290
- Hematology 98
- Molecular Biology 602
- Oncology 222
Countries citing papers authored by Brandi Bailey
This map shows the geographic impact of Brandi Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandi Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandi Bailey more than expected).
Fields of papers citing papers by Brandi Bailey
This network shows the impact of papers produced by Brandi Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandi Bailey. The network helps show where Brandi Bailey may publish in the future.
Co-authors
The 25 scholars most cited alongside Brandi Bailey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 281 | |
| 2 | 2011 | 185 | |
| 3 | 2012 | 114 | |
| 4 | 2008 | 96 | |
| 5 | 2011 | 70 | |
| 6 | 2010 | 68 | |
| 7 | 2012 | 57 | |
| 8 | 2019 | 48 | |
| 9 | 2009 | 34 | |
| 10 | 2012 | 31 | |
| 11 | 2012 | 29 | |
| 12 | In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells | 2004 | 22 |
| 13 | Induction of growth arrest and apoptosis by MNNG is associated with up-regulation of Cdk inhibitor p21 and down-regulation of cyclooxygenase-2 expression | 2004 | 7 |
| 14 | 2004 | 3 | |
| 15 | Mitotic catastrophe induced in cells treated with SDX-105 (Treanda™) | 2005 | 2 |
| 16 | 2016 | 2 | |
| 17 | Brief exposure to SDX-105 (Treanda™) activates potent apoptosis and cell death in lymphoma and leukemia cells | 2005 | 1 |
| 18 | 2015 | 1 | |
| 19 | 2021 | 0 | |
| 20 | 2004 | 0 |
About Brandi Bailey
Brandi Bailey is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Cell Biology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (5 papers), Peptidase Inhibition and Analysis (5 papers), Signaling Pathways in Disease (4 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Mechanisms and Therapy (3 papers), Pluripotent Stem Cells Research (3 papers), Immune Cell Function and Interaction (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Genetics (230 citations), Pathology and Forensic Medicine (290 citations), Hematology (98 citations), Molecular Biology (602 citations) and Oncology (222 citations). Brandi Bailey has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Mark A. Sussman, Natalie Gude, Christopher T. Cottage, Christina C. Niemeyer, Lorenzo M. Leoni, Heather Bendall, Jack Reifert, Jacques Corbeil, Gary Elliott and Kimberlee M. Fischer. Their work appears in journals such as Cancer Research, Circulation Research, Blood, Stem Cells and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.